secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2023-12-07T23:59:59+00:00
Accession:  0000950170-23-068794
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Bio appoints Gilead's Cihlar to board and moves HQ to South San Francisco
--------------------------------------------------------------------------------

- Appointed Tomas Cihlar, Ph.D., Gilead's SVP of Virology, to the Board effective December 7, 2023, per Investor Rights Agreement.
- Dr. Cihlar will not receive compensation for his Board service.
- Corporate headquarters relocated to Two Tower Place, 7th Floor, South San Francisco, CA 94080 effective December 1, 2023.
- The appointment stems from the October 15, 2023 Investor Rights Agreement with Gilead.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000095017023068794/0000950170-23-068794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000095017023068794/asmb-20231201.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-068794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer